Category: ENTIS News

A recent “consensus statement” review article published in Nature Reviews Endocrinology concluded that there is a growing body of evidence supporting the hypothesis that in utero exposure to paracetamol (or acetaminophen, APAP) impacts fetal development. This paper has been widely cited by national media organisations, some of which reported the findings in an alarming manner. ENTIS holds the position that […]

The ENTIS Board are pleased to announce this year’s ENTIS business meeting will be held virtually on 10th November 2021, and will run from 13:30 to 16:30 Central European Time (CET). Details including the agenda and online access instructions will be posted in the members’ only section of the ENTIS website shortly.  The agenda will include an update from each TIS, a case report […]

The ENTIS Board and Scientific Committee are pleased to announce the official position of the ENTIS organisation on the use of COVID-19 vaccines in pregnant and lactating women. In summary, ENTIS holds the position that vaccination is the currently the most effective measure to reduce the risks associated with COVID-19 disease in pregnant women. Current safety data are reassuring, and […]

The ENTIS board and scientific committee are pleased to announce the finalised scientific programme for the 2021 virtual meeting. More details can be found in the Upcoming Virtual Meetings section.

The ENTIS Board and Scientific Committee are happy to announce that Professor Per Damkier (MD, PhD) has been elected as the new chair of the ENTIS Scientific Committee. The Board and Scientific Committee are also pleased to announce that two new members will be joining the committee to replace two retiring members (Professor Hedvig Nordeng and Dr Yusuf Cem Kaplan, […]

Two short debate papers have been published in the British Journal of Obstetrics and Gynaecology discussing the safety of ondansetron use in early pregnancy. Professor Per Damkier in collaboration with the ENTIS Scientific Committee led the argument against avoiding ondansetron use in pregnancy, while Professor Russell Kirby from the College of Public Health, University of South Florida led the argument […]